Neurocrine Biosciences reported $4.2M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Acorda Therapeutics ACOR:US $ 13.3M 1.98M
Adamas Pharmaceuticals ADMS:US 576K 49K
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 49.56M 3.56M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Amgen AMGN:US $ 1609M 28M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Dynavax Technologies DVAX:US $ 60.09M 45.24M
Exelixis EXEL:US $ 11.87M 3.01M
Gilead Sciences GILD:US $ 1223M 167M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Halozyme Therapeutics HALO:US $ 18.59M 4.43M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Intra Cellular Therapies ITCI:US $ 2M 0.04M
IONIS PHARMACEUT IONS:US $ 3M 0.04M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Pfizer PFE:US $ 9931M 2939M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Repligen RGEN:US $ 75.5M 13.5M
Rigel Pharmaceuticals RIGL:US $ 0.15M 0.02M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Teva Pharmaceutical TEVA:IT 1.99B 2M
Ultragenyx Pharmaceutical RARE:US $ 4.18M 1.04M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
YTE INCY:US $ 34.47M 1.84M
Zogenix ZGNX:US $ 1.29M 0.07M